Cell-based drug delivery systems (DDSs) have received attention recently because of their
unique biological properties and self-powered functions, such as excellent biocompatibility …

Abnormal angiogenesis stands for one of the most striking manifestations of malignant
tumor. The pathologically and structurally abnormal tumor vasculature facilitates a hostile …

Injudicious or inappropriate use of antibiotics has led to the prevalence of drug-resistant
bacteria, posing a huge menace to global health. Here, a self-assembled aggregation …

Starvation therapy has been considered a promising strategy in cancer treatment for altering
the tumor microenvironment (TME) and causing a cascade of therapeutic effects. However, it …

In the past five decades, red blood cells (RBCs) have been extensively explored as drug
delivery systems due to their distinguishing potential in modulating the pharmacokinetic …

The tumour‐targeting efficiency of systemically delivered chemodrugs largely dictates the
therapeutic outcome of anticancer treatment. Major challenges lie in the complexity of …

Red blood cells (RBCs) are the most abundant cells in the body, possessing unique
biological and physical properties. RBCs have demonstrated outstanding potential as …

Covalent organic frameworks (COFs) have emerged as promising materials for biomedical
applications, but their functions remain to be explored and the potential toxicity concerns …

Photodynamic therapy (PDT) is approved for the treatment of certain cancers and precancer
lesions. While early Photosensitizers (PS) have found their way to the clinic, research in the …

The progress of precision oncology medicine is always limited by the tumor off‐targeting, the
drug side effects, and the treatment inefficiency due to the complex and ever‐changing …